Chargement en cours...
The role of adjuvant therapy in uterine leiomyosarcoma
Uterine leiomyosarcoma (uLMS) is a rare mesenchymal tumor of the gynecologic tract. Although diagnosed in only 1-3% of patients with uterine cancer, uLMS accounts for the majority of uterine cancer-related deaths. The standard of care for patients with uLMS includes total hysterectomy and bilateral...
Enregistré dans:
| Publié dans: | Expert Rev Anticancer Ther |
|---|---|
| Auteurs principaux: | , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
2015
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4836291/ https://ncbi.nlm.nih.gov/pubmed/26558647 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1586/14737140.2016.1115724 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|